1. Home
  2. SPRU vs ATNM Comparison

SPRU vs ATNM Comparison

Compare SPRU & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spruce Power Holding Corporation

SPRU

Spruce Power Holding Corporation

HOLD

Current Price

$2.82

Market Cap

52.2M

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.16

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRU
ATNM
Founded
2008
2000
Country
United States
United States
Employees
159
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
42.0M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
SPRU
ATNM
Price
$2.82
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
48.2K
207.0K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
62.30
14.17
EPS
N/A
N/A
Revenue
$23,194,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.68
11.11
52 Week Low
$1.13
$0.95
52 Week High
$6.75
$1.95

Technical Indicators

Market Signals
Indicator
SPRU
ATNM
Relative Strength Index (RSI) 28.92 43.40
Support Level $2.51 $0.99
Resistance Level $3.32 $1.25
Average True Range (ATR) 0.21 0.07
MACD -0.05 -0.01
Stochastic Oscillator 10.57 14.81

Price Performance

Historical Comparison
SPRU
ATNM

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: